205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
27.66%
Net income growth above 1.5x MCHP's 13.13%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
3.14%
Some D&A expansion while MCHP is negative at -110.21%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-51.76%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
92.95%
Less working capital growth vs. MCHP's 254.18%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
48.18%
Inventory growth well above MCHP's 87.81%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
116.54%
Lower 'other working capital' growth vs. MCHP's 434.08%. David Dodd would see fewer unexpected short-term demands on cash.
-460.00%
Negative yoy while MCHP is 432.10%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
86.17%
Operating cash flow growth above 1.5x MCHP's 33.08%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
7.30%
Some CapEx rise while MCHP is negative at -70.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
19.49%
Some yoy expansion while MCHP is negative at -31.55%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-19.42%
We reduce yoy sales while MCHP is 48.63%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
8.65%
We have mild expansions while MCHP is negative at -12.30%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while MCHP is 23.73%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
13.27%
Buyback growth of 13.27% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.